Open AccessTop Pharma companies not following current good manufacturing processes: Angiotensin II receptor blockers with carcinogenic impurities: A threat to global public health
Author(s) -
Aslam Pathan,
NeuroPharmac Journal
Publication year - 2019
Publication title -
neuropharmac journal
Language(s) - English
Resource type - Journals
ISSN - 2456-3927
DOI - 10.37881/1.432
Subject(s) - business , carcinogen , current (fluid) , angiotensin ii , public health , angiotensin receptor blockers , impurity , receptor , pharmacology , environmental health , medicine , chemistry , renin–angiotensin system , engineering , biochemistry , nursing , organic chemistry , electrical engineering , blood pressure